Cannabinoid Encyclopedia

Focused research review

TRPV4 cannabinoid target: what the research says

What evidence connects cannabinoids or endocannabinoids with TRPV4 channel activity, binding, or signaling?

Updated July 2026 14 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined TRPV4 cannabinoid target. This page brings together 5 human-study sources, 5 research reviews, and 3 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about TRPV4 cannabinoid target.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on TRPV4 cannabinoid target covers TRPV4; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about TRPV4 cannabinoid target

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

TRPV4

This part of the literature focuses on TRPV4. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

5 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

5 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

3 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 1 of 14 research source could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on TRPV4 cannabinoid target is not one kind of study. This source set includes 5 animal studies, 5 narrative or expert reviews, 2 cell or laboratory studies, and 1 clinical study in people. 3

The recorded populations or models include people or patients (7 sources) and animal models (4 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is tRPV4 channel activity, binding, signaling, or pharmacology (14 sources). Closely related outcome names can still describe different measurements. 5

The TRPV4 cannabinoid target source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Mechanisms of Cell Death Induced by Cannabidiol Against Tumor Cells: A Review of Preclinical Studies.

On this page, this source examines CBD activity involving TRPV4. 1

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
tRPV4 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

animal study

Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4.

On this page, this source examines CBD activity involving TRPV4. 2

Study type
animal study
Population or model
people or patients
Outcome focus
tRPV4 channel activity, binding, signaling, or pharmacology
Evidence stage
mechanism-focused research

narrative or expert review

Cannabinoid Ligands Targeting TRP Channels.

On this page, this source examines THC activity involving TRPV4. 3

Study type
narrative or expert review
Outcome focus
tRPV4 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

clinical study in people

Transcriptomic signature, bioactivity and safety of a non-hepatotoxic analgesic generating AM404 in the midbrain PAG region.

On this page, this source examines Endocannabinoids activity involving TRPV4. 4

Study type
clinical study in people
Population or model
animal models
Outcome focus
tRPV4 channel activity, binding, signaling, or pharmacology
Evidence stage
mechanism-focused research

narrative or expert review

Potential Future Pharmacological Treatment of Bladder Dysfunction.

On this page, this source examines Endocannabinoids activity involving TRPV4. 5

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
tRPV4 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on TRPV4 cannabinoid target should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects cannabinoids or endocannabinoids with TRPV4 channel activity, binding, or signaling?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Mechanisms of Cell Death Induced by Cannabidiol Against Tumor Cells: A Review of Preclinical Studies. narrative or expert review; evidence still limited PubMed 40006844 DOI 10.3390/plants14040585
  2. 2
    Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. animal study; mechanism-focused research PubMed 33629929 DOI 10.1080/15548627.2021.1885203
  3. 3
    Cannabinoid Ligands Targeting TRP Channels. narrative or expert review; evidence still limited PubMed 30697147 DOI 10.3389/fnmol.2018.00487
  4. 4
    Transcriptomic signature, bioactivity and safety of a non-hepatotoxic analgesic generating AM404 in the midbrain PAG region. clinical study in people; mechanism-focused research PubMed 38750093 DOI 10.1038/s41598-024-61791-z
  5. 5
    Potential Future Pharmacological Treatment of Bladder Dysfunction. narrative or expert review; evidence still limited PubMed 26990140 DOI 10.1111/bcpt.12577
  6. 6
    Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. narrative or expert review; evidence still limited PubMed 19070372 DOI 10.1016/j.tips.2008.10.008
  7. 7
    Toward an effective peripheral visceral analgesic: responding to the national opioid crisis. narrative or expert review; evidence still limited PubMed 29470146 DOI 10.1152/ajpgi.00013.2018
  8. 8
    Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. animal study; mechanism-focused research PubMed 21726418 DOI 10.1111/j.1748-1716.2011.02338.x
  9. 9
    Modification of TRPV4 activity by acetaminophen. animal study; mechanism-focused research PubMed 32051870 DOI 10.1016/j.heliyon.2020.e03301
  10. 10
    Peripheral cannabinoid receptor activation attenuates frostbite-induced chronic pain via modulation of TRP channels, neuroinflammation, and autophagy. animal study; mechanism-focused research PubMed 41802611 DOI 10.1016/j.freeradbiomed.2026.02.059
  11. 11
    Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol. animal study; mechanism-focused research PubMed 26294342 DOI 10.1111/bph.13312
  12. 12
    An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors. evidence still limited PubMed 33362478 DOI 10.3389/fncel.2020.615811
See all 14 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Cannabinoid Ligands Targeting TRP Channels. narrative or expert review; evidence still limited / 1 linked research note PubMed 30697147
  2. An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors. evidence still limited / 1 linked research note PubMed 33362478
  3. Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. animal study; mechanism-focused research / 1 linked research note PubMed 33629929
  4. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. animal study; mechanism-focused research / 1 linked research note PubMed 21726418
  5. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. narrative or expert review; evidence still limited / 1 linked research note PubMed 19070372
  6. Human podocytes express functional thermosensitive TRPV channels. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 28945920
  7. Modification of TRPV4 activity by acetaminophen. animal study; mechanism-focused research / 1 linked research note PubMed 32051870
  8. Transcriptomic signature, bioactivity and safety of a non-hepatotoxic analgesic generating AM404 in the midbrain PAG region. clinical study in people; mechanism-focused research / 1 linked research note PubMed 38750093
  9. Toward an effective peripheral visceral analgesic: responding to the national opioid crisis. narrative or expert review; evidence still limited / 1 linked research note PubMed 29470146
  10. Potential Future Pharmacological Treatment of Bladder Dysfunction. narrative or expert review; evidence still limited / 1 linked research note PubMed 26990140
  11. Peripheral cannabinoid receptor activation attenuates frostbite-induced chronic pain via modulation of TRP channels, neuroinflammation, and autophagy. animal study; mechanism-focused research / 1 linked research note PubMed 41802611
  12. Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol. animal study; mechanism-focused research / 1 linked research note PubMed 26294342
  13. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 25061872
  14. Mechanisms of Cell Death Induced by Cannabidiol Against Tumor Cells: A Review of Preclinical Studies. narrative or expert review; evidence still limited / 1 linked research note PubMed 40006844